| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-2952(98)00010-0 |
| P698 | PubMed publication ID | 9634003 |
| P2093 | author name string | Y Hamada | |
| T Taguchi | |||
| M Sugiura | |||
| I Miwa | |||
| P2860 | cites work | Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals | Q28328519 |
| Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat | Q34762247 | ||
| Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition. | Q40449638 | ||
| Mice lacking tissue non-specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. | Q42275955 | ||
| Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats | Q44297704 | ||
| Serum pyridoxal and folate concentrations in diabetics | Q67827836 | ||
| A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus | Q67961388 | ||
| Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation | Q67972957 | ||
| Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine | Q71004537 | ||
| Effects of aminoguanidine and pyridoxal phosphate on glycation reaction of aspartate aminotransferase and serum albumin | Q71895303 | ||
| Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation | Q72068618 | ||
| Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat | Q72345792 | ||
| Highly sensitive and simple liquid chromatographic determination in plasma of B6 vitamers, especially pyridoxal 5'-phosphate | Q73036632 | ||
| Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats | Q73829192 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1667-1671 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate | |
| P478 | volume | 55 |
| Q35576070 | Carbonyl Stress and Diabetic Complications |
| Q37193283 | Crystal structure of bis-{4-bromo-2-[(carb-amim-id-amido-imino)-meth-yl]phenolato-κ(3) N,N',O}cobalt(III) nitrate di-methyl-formamide monosolvate. |
| Q46081234 | Design, synthesis, and evaluation of carnosine derivatives as selective and efficient sequestering agents of cytotoxic reactive carbonyl species |
| Q46007995 | Glycation of aspartate aminotransferase by methylglyoxal, effect of hydroxycitric and uric acid. |
| Q38556600 | High throughput assay for evaluation of reactive carbonyl scavenging capacity. |
| Q84816901 | Inhibition of advanced glycation end-product formation on eye lens protein by rutin |
| Q73009476 | Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal |
| Q36568547 | Lipoxidation-derived reactive carbonyl species as potential drug targets in preventing protein carbonylation and related cellular dysfunction |
| Q46593878 | Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study |
| Q44166254 | Two new nitric oxide synthase inhibitors: pyridoxal aminoguanidine and 8-quinolinecarboxylic hydrazide selectively inhibit basal but not agonist-stimulated release of nitric oxide in rat aorta |
| Q35563874 | Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts |
Search more.